Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing.
The Malvern, Pa.–based company had sought to raise a total $3 million, according to the SEC Form D filed Dec. 4.
The company said a month later that Checkmate Capital, a strategic investment group based in Los Angeles and Beijing, had agreed to an initial Series B investment.
Tela Bio’s OviTex reinforced bioscaffolds products are meant for hernia repair and abdominal wall reconstruction. They compbine polymer and biologic materials in what the company describes as a uniquely embroidered construction.